Clinical trial
Renal Function Among Thalassemia Patients Treated by a Oral Chelator Deferasirox
NCT01905774 is registered in ClinicalTrials.gov with HaEmek Medical Center, Israel as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Renal Function Among Thalassemia Patients Treated by a Oral Chelator Deferasirox
- Lead sponsor
- HaEmek Medical Center, Israel
- Phase
- Observational
- Overall status
- Completed
- Start date
- March 31, 2011
- Completion date
- August 31, 2015
- Enrollment
- 36 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.